Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IT3-H52W8 | Human | Human Integrin alpha 2b beta 3 (ITGAIIb&ITGB3) Heterodimer Protein, His Tag&Tag Free |  |
|
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Tirofiban Hydrochloride Hydrate | L-462; MK-383; MK-0383; L-700462 | Approved | Merck Sharp & Dohme Corp | 欣维宁, 艾卡特, Aggrastat | United States | Acute Coronary Syndrome; Coronary Thrombosis; Thrombosis | Medicure Inc | 1998-05-14 | Angina, Unstable; Myocardial Infarction; Renal Insufficiency; Acute Coronary Syndrome; Stroke; Coronary Thrombosis; Ischemic Stroke; Cardiovascular Diseases; Cerebral Infarction; Thrombosis | Details |
| Abciximab biosimilar (ISU Abxis) | ISU-301 | Approved | Isu Abxis Co Ltd | Clotinab, Faximab | Myocardial Ischemia; Myocardial Infarction | Details | ||||
| Abciximab | c7E3-Fab; c7E3-F(ab)2 | Approved | Eli Lilly And Company, Johnson & Johnson Innovative Medicine | ReoPro | United States | Myocardial Ischemia | Janssen Biotech Inc | 1994-12-22 | Brain Ischemia; Myocardial Ischemia; Angina, Unstable; Arterial Occlusive Diseases; Myocardial Infarction; ST Elevation Myocardial Infarction; Stroke; Acute Disease; Carotid Stenosis; Constriction, Pathologic; Renal Artery Obstruction | Details |
| Abciximab biosimilar (Reliance Life Sciences) | R-TPR-019 | Approved | Reliance Life Sciences | AbcixiRel | India | Angina, Unstable; Myocardial Ischemia | Reliance Life Sciences | 2013-01-01 | Myocardial Ischemia; Angina, Unstable | Details |
| Eptifibatide | CN-102702321; Sch-60936; SB-1; C68-22 | Approved | Millennium Pharmaceuticals Inc | Integrelin (former Brand Name), Integrilin | EU | Angina, Unstable; Myocardial Infarction | Glaxosmithkline (Ireland) Ltd | 1998-05-18 | Myocardial Infarction; Angina, Unstable; ST Elevation Myocardial Infarction; Acute Coronary Syndrome; Anemia, Sickle Cell | Details |
| Bevifibatide Citrate | BAT-2094; BAT2094 | Approved | Bio-Thera Solutions Ltd | 贝塔宁, BETAGRIN | Mainland China | Acute Coronary Syndrome | Bio-Thera Solutions Ltd | 2024-06-25 | Myocardial Ischemia; Myocardial Infarction; Angina, Unstable; Angina Pectoris; Acute Coronary Syndrome; Non-ST Elevated Myocardial Infarction; Thrombosis | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Zalunfiban | RUC-4 | Phase 3 Clinical | The Rockefeller University | ST Elevation Myocardial Infarction | Details |
| MT-1002(Shaanxi Micot Technology) | MT-1002 | Phase 2 Clinical | Shaanxi Micot Technology Co Ltd | Blood Coagulation Disorders; ST Elevation Myocardial Infarction; Angina, Unstable; Acute Coronary Syndrome; Stroke; Thrombocytopenia; Thrombosis; Non-ST Elevated Myocardial Infarction | Details |
| Pury Peptide | MT-1001 | Phase 2 Clinical | Shaanxi Micot Technology Co Ltd | Acute Coronary Syndrome | Details |
| BGC-728 | BGC-728 | Phase 2 Clinical | Btg Plc | Myocardial Infarction; Stroke | Details |
| EGT-022 | EG-22; HU-005; EGT-022 | Phase 2 Clinical | Eyegene Inc | Pressure Ulcer | Details |
| HYC-11395 | HYC-11395 | Phase 1 Clinical | Hefei Cosource Medicine Technology, Nanjing Heqi Pharmaceutical Technology Co Ltd | Coronary Artery Disease; Thromboembolism | Details |
| XU-070 | XU-070 | Bristol-Myers Squibb Pharma Company | Details |
This web search service is supported by Google Inc.
A-Z
